Answers are grounded in this paper and cite their sources.
We showed that trabectedin may not only inhibit but also enhance the binding of EWS-FLI1 to certain target genes, leading to upregulation of IGF1R. We here provide the rationale for combining trabectedin to anti-IGF1R inhibitors.
No takes yet. Share an insight, caveat, or question.
Amaral et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: